Blueprint Medicines Corp
BPMCDelisted Jul 18, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001597264
Blueprint Medicines Corp was delisted on Jul 18, 2025; its insiders filed their last Form 4 on Jul 21, 2025; 356 institutions reported holding it in 13F filings for Q2 2025, worth $8.65B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding BPMC, Q2 2025
1 superinvestor reports holding Blueprint Medicines Corp on Form 13F, worth $32.0M in total. Weight is Blueprint Medicines Corp's share of each 13F portfolio; actions compare shares with Q1 2025.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.5% | 250,000 | $32.0M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BPMC each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2025
1 superinvestor holding at quarter end
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q2 2021
1 superinvestor holding at quarter end
- Reduced
- HHLR Advisors (Hillhouse) (−16.3%)
- Sold out
- Lone Pine Capital, Viking Global Investors